| Date | Company Name | Action | Current
Price | Price
Target | Rating | Impact on
Share Price |
|---|
| 1/27/2023 | XERS Xeris Biopharma | Lower Price Target | $1.00 | $6.00 ➝ $5.00 | Outperform | Low |
| 1/27/2023 | VIR Vir Biotechnology | Lower Price Target | $31.00 | $45.00 ➝ $43.00 | Outperform | Low |
| 1/27/2023 | SCPH scPharmaceuticals | Boost Price Target | $6.00 | $12.00 ➝ $13.00 | Outperform | Low |
| 1/27/2023 | PRDS Pardes Biosciences | Lower Price Target | $2.00 | $12.00 ➝ $9.00 | Outperform | Low |
| 1/27/2023 | ENTA Enanta Pharmaceuticals | Lower Price Target | $52.00 | $50.00 ➝ $49.00 | Market Perform | Low |
| 1/27/2023 | AVIR Atea Pharmaceuticals | Lower Price Target | $5.00 | $8.00 ➝ $6.00 | Market Perform | Low |
| 1/26/2023 | ELV Elevance Health | Reiterated Rating | $493.00 | $580.00 | Outperform | Low |
| 1/24/2023 | BHVN Biohaven | Reiterated Rating | $19.00 | $24.00 | Outperform | Low |
| 1/24/2023 | PLRX Pliant Therapeutics | Boost Price Target | $35.00 | $33.00 ➝ $45.00 | Outperform | Low |
| 1/23/2023 | RXRX Recursion Pharmaceuticals | Lower Price Target | $9.00 | $9.00 ➝ $8.00 | Market Perform | Low |
| 1/23/2023 | RGNX REGENXBIO | Lower Price Target | $23.00 | $15.00 ➝ $14.00 | Market Perform | Low |
| 1/23/2023 | RCKT Rocket Pharmaceuticals | Lower Price Target | $22.00 | $50.00 ➝ $49.00 | Outperform | Low |
| 1/23/2023 | NTLA Intellia Therapeutics | Lower Price Target | $42.00 | $86.00 ➝ $84.00 | Outperform | Low |
| 1/23/2023 | IONS Ionis Pharmaceuticals | Boost Price Target | $40.00 | $32.00 ➝ $33.00 | Market Perform | Low |
| 1/23/2023 | EDIT Editas Medicine | Boost Price Target | $10.00 | $6.00 ➝ $7.00 | Market Perform | Low |
| 1/23/2023 | DBTX Decibel Therapeutics | Lower Price Target | $3.00 | $10.00 ➝ $7.00 | Outperform | Low |
| 1/23/2023 | BLUE bluebird bio | Lower Price Target | $6.00 | $9.00 ➝ $8.00 | Market Perform | Low |
| 1/23/2023 | BEAM Beam Therapeutics | Lower Price Target | $45.00 | $81.00 ➝ $77.00 | Outperform | Low |
| 1/23/2023 | BBIO BridgeBio Pharma | Lower Price Target | $9.00 | $23.00 ➝ $19.00 | Outperform | Low |
| 1/23/2023 | ALVR AlloVir | Lower Price Target | $6.00 | $25.00 ➝ $19.00 | Outperform | Low |
| 1/23/2023 | ALNY Alnylam Pharmaceuticals | Lower Price Target | $231.00 | $144.00 ➝ $143.00 | Market Perform | Low |
| 1/23/2023 | RLMD Relmada Therapeutics | Lower Price Target | $4.00 | $42.00 ➝ $10.00 | Outperform | Low |
| 1/23/2023 | MRNS Marinus Pharmaceuticals | Lower Price Target | $6.00 | $27.00 ➝ $23.00 | Outperform | Low |
| 1/23/2023 | MRK Merck & Co., Inc. | Boost Price Target | $105.00 | $112.00 ➝ $120.00 | Outperform | Low |
| 1/20/2023 | JNJ Johnson & Johnson | Lower Price Target | $168.00 | $194.00 ➝ $186.00 | Outperform | Low |
| 1/20/2023 | BGNE BeiGene | Boost Price Target | $260.00 | $236.00 ➝ $300.00 | Outperform | Low |
| 1/20/2023 | SGEN Seagen | Boost Price Target | $141.00 | $160.00 ➝ $162.00 | Outperform | Low |
| 1/20/2023 | ZYME Zymeworks | Boost Price Target | $10.00 | $8.00 ➝ $10.00 | Market Perform | Low |
| 1/20/2023 | SRPT Sarepta Therapeutics | Reiterated Rating | $123.00 | $160.00 | Outperform | Low |
| 1/19/2023 | EOLS Evolus | Boost Price Target | $10.00 | $18.00 ➝ $20.00 | Outperform | Low |
| 1/18/2023 | MRNA Moderna | Boost Price Target | $189.00 | $102.00 ➝ $111.00 | Market Perform | Low |
| 1/17/2023 | VRTX Vertex Pharmaceuticals | Upgrade | $321.00 | $374.00 | Market Perform ➝ Outperform | Low |
| 1/12/2023 | HOLX Hologic | Boost Price Target | $83.00 | $85.00 ➝ $90.00 | Outperform | Low |
| 1/12/2023 | EXAS Exact Sciences | Boost Price Target | $67.00 | $70.00 ➝ $75.00 | Outperform | Low |
| 1/11/2023 | HALO Halozyme Therapeutics | Lower Price Target | $51.00 | $62.00 ➝ $61.00 | Outperform | Low |
| 1/10/2023 | OSH Oak Street Health | Boost Price Target | $29.00 | $23.00 ➝ $33.00 | Market Perform | Low |
| 1/10/2023 | TSVT 2seventy bio | Lower Price Target | $13.00 | $41.00 ➝ $34.00 | Outperform | Low |
| 1/10/2023 | KPTI Karyopharm Therapeutics | Lower Price Target | $3.00 | $6.00 ➝ $5.00 | Market Perform | Low |
| 1/10/2023 | EDIT Editas Medicine | Lower Price Target | $10.00 | $7.00 ➝ $6.00 | Market Perform | Low |
| 1/10/2023 | MIRM Mirum Pharmaceuticals | Lower Price Target | $24.00 | $50.00 ➝ $39.00 | Outperform | Low |
| 1/9/2023 | AMYT Amryt Pharma | Downgrade | $15.00 | $19.00 ➝ $14.50 | Outperform ➝ Market Perform | Low |
| 1/9/2023 | VRDN Viridian Therapeutics | Boost Price Target | $36.00 | $40.00 ➝ $45.00 | Outperform | Low |
| 1/6/2023 | GRPH Graphite Bio | Downgrade | $2.00 | $11.00 ➝ $2.00 | Outperform ➝ Market Perform | Low |
| 1/6/2023 | IPSC Century Therapeutics | Lower Price Target | $5.00 | $20.00 ➝ $14.00 | Outperform | Low |
| 1/6/2023 | FATE Fate Therapeutics | Lower Price Target | $6.00 | $62.00 ➝ $10.00 | Outperform | N/A |
| 1/6/2023 | WAT Waters | Boost Price Target | $333.00 | $320.00 ➝ $352.00 | Market Perform | Low |
| 1/6/2023 | TMO Thermo Fisher Scientific | Boost Price Target | $574.00 | $555.00 ➝ $620.00 | Outperform | Low |
| 1/6/2023 | RGEN Repligen | Lower Price Target | $195.00 | $230.00 ➝ $200.00 | Outperform | Low |
| 1/6/2023 | MASS 908 Devices | Lower Price Target | $9.00 | $25.00 ➝ $20.00 | Outperform | Low |
| 1/6/2023 | ABCL AbCellera Biologics | Lower Price Target | $11.00 | $20.00 ➝ $18.00 | Outperform | Low |
| 1/6/2023 | A Agilent Technologies | Boost Price Target | $156.00 | $160.00 ➝ $170.00 | Outperform | Low |
| 1/6/2023 | HOLX Hologic | Boost Price Target | $83.00 | $78.00 ➝ $85.00 | Outperform | Low |
| 1/6/2023 | EXAS Exact Sciences | Boost Price Target | $67.00 | $60.00 ➝ $70.00 | Outperform | Low |
| 1/6/2023 | BLUE bluebird bio | Boost Price Target | $6.00 | $8.00 ➝ $9.00 | Market Perform | Low |
| 1/5/2023 | PHR Phreesia | Boost Price Target | $36.00 | $34.00 ➝ $39.00 | Outperform | Low |
| 1/5/2023 | PGNY Progyny | Reiterated Rating | $34.00 | $59.00 ➝ $34.00 | Outperform ➝ Market Perform | Low |
| 1/5/2023 | COGT Cogent Biosciences | Boost Price Target | $14.00 | $18.00 ➝ $20.00 | Outperform | Low |
| 1/5/2023 | AMED Amedisys | Lower Price Target | $93.00 | $96.00 ➝ $85.00 | Market Perform | Low |
| 1/4/2023 | DCPH Deciphera Pharmaceuticals | Boost Price Target | $17.00 | $25.00 ➝ $28.00 | Outperform | Low |
| 12/27/2022 | AMTI Applied Molecular Transport | Reiterated Rating | $1.00 | | Outperform ➝ Market Perform | Low |
| 12/22/2022 | RCKT Rocket Pharmaceuticals | Lower Price Target | $22.00 | $54.00 ➝ $50.00 | Outperform | Low |
| 12/22/2022 | ISO IsoPlexis | Lower Price Target | $1.00 | $2.50 ➝ $1.50 | Market Perform | Low |
| 12/22/2022 | AMGN Amgen | Boost Price Target | $254.00 | $256.00 ➝ $282.00 | Market Perform | Low |
| 12/20/2022 | NAMS NewAmsterdam Pharma | Initiated Coverage | $16.00 | $19.00 | Outperform | Low |
| 12/20/2022 | MDGL Madrigal Pharmaceuticals | Boost Price Target | $290.00 | $145.00 ➝ $315.00 | Outperform | Low |
| 12/19/2022 | ROIV Roivant Sciences | Boost Price Target | $9.00 | $8.00 ➝ $10.00 | Outperform | Low |
| 12/16/2022 | LLY Eli Lilly and | Boost Price Target | $342.00 | $384.00 ➝ $410.00 | Outperform | Low |
| 12/16/2022 | HCA HCA Healthcare | Boost Price Target | $255.00 | $238.00 ➝ $286.00 | Outperform | Low |
| 12/16/2022 | AXLA Axcella Health | Reiterated Rating | $1.00 | $6.00 ➝ $2.00 | Outperform ➝ Market Perform | Low |
| 12/16/2022 | PCVX Vaxcyte | Reiterated Rating | $46.00 | $60.00 | Outperform | Low |
| 12/15/2022 | KYMR Kymera Therapeutics | Boost Price Target | $37.00 | $26.00 ➝ $31.00 | Market Perform | Low |
| 12/14/2022 | MIRM Mirum Pharmaceuticals | Boost Price Target | $24.00 | $49.00 ➝ $50.00 | Outperform | Low |
| 12/14/2022 | MRTX Mirati Therapeutics | Lower Price Target | $53.00 | $85.00 ➝ $75.00 | Outperform | Low |
| 12/14/2022 | WVE Wave Life Sciences | Boost Price Target | $4.00 | $2.00 ➝ $7.00 | Market Perform | Low |
| 12/13/2022 | FATE Fate Therapeutics | Lower Price Target | $6.00 | $64.00 ➝ $62.00 | Outperform | Low |
| 12/13/2022 | HZNP Horizon Therapeutics Public | Downgrade | $111.00 | $88.00 ➝ $116.50 | Outperform ➝ Market Perform | Low |
| 12/13/2022 | SPRY ARS Pharmaceuticals | Initiated Coverage | $6.00 | $14.00 | Outperform | Low |
| 12/13/2022 | NRIX Nurix Therapeutics | Lower Price Target | $12.00 | $37.00 ➝ $28.00 | Outperform | Low |
| 12/13/2022 | MRNA Moderna | Boost Price Target | $189.00 | $101.00 ➝ $102.00 | Market Perform | Low |
| 12/12/2022 | AFMD Affimed | Lower Price Target | $1.00 | $10.00 ➝ $6.00 | Outperform | Low |
| 12/12/2022 | BGNE BeiGene | Boost Price Target | $260.00 | $210.00 ➝ $236.00 | Outperform | Low |
| 12/9/2022 | PHR Phreesia | Upgrade | $36.00 | $31.00 ➝ $34.00 | Market Perform ➝ Outperform | Low |
| 12/9/2022 | DSGN Design Therapeutics | Lower Price Target | $8.00 | $30.00 ➝ $22.00 | Outperform | Low |
| 12/8/2022 | MRTX Mirati Therapeutics | Lower Price Target | $53.00 | $102.00 ➝ $85.00 | Outperform | Low |
| 12/7/2022 | GOSS Gossamer Bio | Lower Price Target | $2.00 | $15.00 ➝ $10.00 | Outperform | Low |
| 12/7/2022 | REPL Replimune Group | Boost Price Target | $26.00 | $30.00 ➝ $34.00 | Outperform | Low |
| 12/6/2022 | RCKT Rocket Pharmaceuticals | Lower Price Target | $22.00 | $56.00 ➝ $54.00 | Outperform | Low |
| 12/2/2022 | NTLA Intellia Therapeutics | Lower Price Target | $42.00 | $90.00 ➝ $86.00 | Outperform | Low |
| 12/2/2022 | VEEV Veeva Systems | Lower Price Target | $171.00 | $242.00 ➝ $233.00 | Outperform | Low |
| 11/30/2022 | FUSN Fusion Pharmaceuticals | Initiated Coverage | $3.00 | $6.00 | Outperform | Low |
| 11/30/2022 | PNT POINT Biopharma Global | Initiated Coverage | $7.00 | $14.00 | Outperform | Low |
| 11/30/2022 | LNTH Lantheus | Initiated Coverage | $56.00 | | Outperform | Low |
| 11/29/2022 | ARWR Arrowhead Pharmaceuticals | Lower Price Target | $34.00 | $33.00 ➝ $31.00 | Market Perform | Low |
| 11/29/2022 | AXSM Axsome Therapeutics | Boost Price Target | $70.00 | $65.00 ➝ $85.00 | Outperform | Low |
| 11/29/2022 | OABI OmniAb | Initiated Coverage | $4.00 | $6.00 | Outperform | Low |
| 11/24/2022 | ACLX Arcellx | Lower Price Target | $34.00 | $35.00 | | Low |
| 11/24/2022 | FATE Fate Therapeutics | Set Price Target | $6.00 | $64.00 | | Low |
| 11/22/2022 | A Agilent Technologies | Boost Price Target | $156.00 | $145.00 ➝ $160.00 | Outperform | Low |
| 11/22/2022 | SGRY Surgery Partners | Lower Price Target | $33.00 | $55.00 ➝ $40.00 | Outperform | Low |
| 11/22/2022 | ARVN Arvinas | Lower Price Target | $32.00 | $89.00 ➝ $74.00 | Outperform | Low |
